Carregant...
Landiolol for managing atrial fibrillation in intensive care
Landiolol is an injectable ultrashort acting beta-blocker with high beta1 selectivity indicated for heart rate control of atrial fibrillation in the emergency and critical care setting. Accordingly, landiolol is associated with a significantly reduced risk of arterial hypotension and negative inotro...
Guardat en:
| Publicat a: | Eur Heart J Suppl |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909768/ https://ncbi.nlm.nih.gov/pubmed/30188960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux039 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|